✨ Free AI Report
Trinity Biotech plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Trinity Biotech plc
Company Research

Trinity Biotech plc: Business Overview, Financials & Competitive Analysis

Trinity Biotech plc scores 4/10 on the AskCyborg Cyborg Score (Mixed). Commercial momentum and regulatory product wins balanced against significant near-term Nasdaq compliance risk and capital constraints. Q3 2025 showed positive momentum with revenue of $14.3M (+32% vs Q2 2025) and Adjusted EBITDA improvement to $0.5M from -$2.1M in Q2. However, the company faces regulatory challenges, with non-compliance with Nasdaq.

What is Trinity Biotech plc's industry? Trinity Biotech plc (trinitybiotech.com) operates in Clinical Diagnostics & Medical Devices. AskCyborg classifies Trinity Biotech plc under Clinical Diagnostics & Medical Devices in its company registry.

Trinity Biotech develops, manufactures, and markets clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. The company operates across infectious disease testing (HIV...

4/ 10Mixed

Cyborg Score thesis

Commercial momentum and regulatory product wins balanced against significant near-term Nasdaq compliance risk and capital...

Read the full analyst-debate transcript →
Industry Clinical Diagnostics & Medical Devices
4 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Trinity Biotech plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Trinity Biotech plc

AskCyborg analysts argue the bull and bear cases for Trinity Biotech plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Trinity Biotech plc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Trinity Biotech plc Overview

Pro stress-test →

Trinity Biotech develops, manufactures, and markets clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. The company operates across infectious disease testing (HIV), diabetes management (HbA1c analyzers), and emerging continuous glucose monitoring technology, with recent strong momentum in global HIV testing driven by WHO-approved manufacturing models.

Strategic Profile

Pro stress-test →

Trinity Biotech is executing a Comprehensive Transformation Plan with WHO approval for outsourced manufacturing and expects further Adjusted EBITDA improvement. The company's Premier Hb9210 HbA1c Analyser achieved the prestigious IFCC Gold Classification for 2026, making it the only HbA1c system worldwide to earn this certification. The company is advancing next-generation CGM+ continuous glucose monitoring with needle-free sensor technology.

Competitive Landscape

Pro stress-test →

Bio-Rad Laboratories, Diasorin, Luminex, and Abbott are competitors of Trinity Biotech. Trinity differentiates through point-of-care diagnostic products, WHO-prequalified HIV tests with manufacturing cost advantages, and FDA-cleared diabetes monitoring technology recognized for superior accuracy certification.

Industry Context

Trinity Biotech plc operates in Clinical Diagnostics & Medical Devices.

Key facts

Founded: 1992 · Headquarters: Bray, Ireland · Revenue: $48.6M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Trinity Biotech plc.

  • Received a 9 million-unit WHO-prequalified TrinScreen HIV rapid test order with fulfillment in Q4 2025 and Q1 2026.
  • Received full regulatory approval for upstream manufacturing of flagship Uni-Gold HIV rapid test under offshored and outsourced production model, the final major regulatory milestone for manufacturing transformation.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Secured $25M SEPA financing commitment with Yorkville Advisors Global for commercialization and R&D
  • February 2026Premier Hb9210 HbA1c Analyzer awarded IFCC Gold Classification, only system to earn 2026 certification
  • +2 moreTrack every material event for Trinity Biotech plc as it happens. Explore monitoring →
Get alerted when Trinity Biotech plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Clinical DiagnosticsGlobal clinical diagnostic products→Diagnostic ProductsIn vitro diagnostic solutions→Diagnostic InstrumentsMultiplexed testing platforms→Diagnostics PortfolioBroad diagnostic product range→

Compare Trinity Biotech plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Trinity Biotech plc operates in Clinical Diagnostics & Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Clinical Diagnostics & Medical Devices research →
NEW · MCP server

Ask your AI assistant about Trinity Biotech plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Trinity Biotech plc and its top competitor on Cyborg Score”
“What did Trinity Biotech plc do this quarter?”
“Is Trinity Biotech plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Trinity Biotech plc do?+
Trinity Biotech develops, manufactures, and markets clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. The company operates across infectious disease testing (HIV...
What is Trinity Biotech plc's Cyborg Score?+
Trinity Biotech plc has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Trinity Biotech plc's main competitors?+
Named competitors include Clinical Diagnostics, Diagnostic Products, Diagnostic Instruments, Diagnostics Portfolio. The full competitive landscape is in the AskCyborg report.
How can I get the full Trinity Biotech plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Trinity Biotech plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Trinity Biotech plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Clinical Diagnostics & Medical Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Eiken Chemical Co., Ltd.